SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

Clinical trial NCT02970682 · COMPLETED

Trial details

NCT number: NCT02970682
Sponsor: Evgen Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2016-10-01
Primary completion: 2019-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.